Loading
Search
▼ FOCUS: Bidding War May Break Out For Toshiba, More Business Reform Likely
- Category:Other
With a recent buyout offer for Toshiba Corp. from a British private equity firm apparently hitting a snag, a bidding war involving other investors may break out for the Japanese industrial conglomerate, industry experts say.
Investor interest in the growth potential of some of Toshiba's businesses, such as chip-making and infrastructure systems, means the company is likely to face continued pressure to streamline its wide-ranging operations, they say.
Toshiba's management rift widened after CVC Capital Partners made a buyout offer worth over $20 billion, leading its board members to believe the former president and CEO Nobuaki Kurumatani, once a CVC executive, was pulling strings to fend off pressure from activist shareholders.
Toshiba said Wednesday Kurumatani, who has led the company since 2018, offered to resign. He said in a statement he wants to take some time for himself after achieving the company's turnaround without making any reference to the CVC proposal.
Osamu Nagayama, chairman of Toshiba's board, confronted Kurumatani in the boardroom and expressed displeasure with CVC's buyout offer, sources with knowledge of the matter have said.
Nagayama and some other board members are believed to have raised questions about Kurumatani's stance of preventing activist shareholders from wielding influence.
Aiming to block CVC's acquisition plans and keep Toshiba listed on the Tokyo bourse, the conglomerate's executives asked creditor banks not to fund the private equity firm's buyout, according to people close to the matter.
CVC had previously planned to submit a detailed proposal in 10 days after sending its initial plan to Toshiba on April 6, while seeking cooperation from the Development Bank of Japan and Japan Investment Corp., a private-public sector fund, other sources have said.
But CVC did not deliver the formal offer by Friday, as it was seemingly monitoring the situation after Kurumatani's resignation with the possibility of launching a hostile takeover bid.
American global investment firm Kohlberg Kravis Roberts & Co. and Canadian investment giant Brookfield Asset Management Inc. reportedly plan to submit buyout proposals of their own.
Aiming to block CVC's acquisition plans and keep Toshiba listed on the Tokyo bourse, the conglomerate's executives asked creditor banks not to fund the private equity firm's buyout, according to people close to the matter.
CVC had previously planned to submit a detailed proposal in 10 days after sending its initial plan to Toshiba on April 6, while seeking cooperation from the Development Bank of Japan and Japan Investment Corp., a private-public sector fund, other sources have said.
But CVC did not deliver the formal offer by Friday, as it was seemingly monitoring the situation after Kurumatani's resignation with the possibility of launching a hostile takeover bid.
American global investment firm Kohlberg Kravis Roberts & Co. and Canadian investment giant Brookfield Asset Management Inc. reportedly plan to submit buyout proposals of their own.
"Investors are interested in Toshiba's chip-making affiliate Kioxia Holdings Corp.," possibly outbidding CVC, SBI Securities Co.'s senior analyst Yoshiharu Izumi said.
A global shortage of semiconductors due to robust demand for automobiles, smartphones and other electronic devices has spotlighted chipmakers.
Toshiba owns a 40.64 percent stake in Kioxia, into which the Japanese firm spun off its chip business after selling a majority stake to a consortium led by U.S. private equity firm Bain Capital in 2018. Toshiba plans to list Kioxia and use a large part of the proceeds to increase shareholder returns.
Tatsuo Ushijima, a professor specializing in corporate strategy at Keio University, said going private makes sense for Toshiba to further reform its group operations.
"Toshiba would need to review its wide-ranging businesses (from nuclear power to home lighting equipment) in an environment with fewer investors holding its shares," Ushijima said.
"Toshiba must at first outline its growth strategy regardless of whether it is going it alone or working with partners."
A global shortage of semiconductors due to robust demand for automobiles, smartphones and other electronic devices has spotlighted chipmakers.
Toshiba owns a 40.64 percent stake in Kioxia, into which the Japanese firm spun off its chip business after selling a majority stake to a consortium led by U.S. private equity firm Bain Capital in 2018. Toshiba plans to list Kioxia and use a large part of the proceeds to increase shareholder returns.
Tatsuo Ushijima, a professor specializing in corporate strategy at Keio University, said going private makes sense for Toshiba to further reform its group operations.
"Toshiba would need to review its wide-ranging businesses (from nuclear power to home lighting equipment) in an environment with fewer investors holding its shares," Ushijima said.
"Toshiba must at first outline its growth strategy regardless of whether it is going it alone or working with partners."
- April 17, 2021
- Comment (1217)
- Trackback(0)
Comment(s) Write comment
generic viagra 150 mg online <a href="https://seinviagro.com/ ">generic sildenafil usa</a> viagra 25 mg price
-
Jrvxgaima Web Site
- August 6, 2022
cialis 20mg canada <a href="https://cialpriceus.com/ ">pharmaglobalrx tadalafil</a> canadian pharmacy cialis 40 mg
-
Nexzgaima Web Site
- August 5, 2022
300 mg viagra <a href="https://tabviagrleo.com/ ">sildenafil 50mg tablets</a> order viagra europe
-
Jikagaima Web Site
- August 5, 2022
amoxil oral suspension <a href="https://amoxilus.com/#">amoxicillin for sale for humans </a> pet amoxicillin therapy course amoxil for borrelia
-
viagra challenge Web Site
- August 5, 2022
viagra online canada no prescription <a href="https://tabviagrleo.com/ ">viagra soft cheap</a> viagra 150 mg prices
-
Jikagaima Web Site
- August 4, 2022
best over the counter viagra pill <a href="https://sildenaflabc.com/ ">viagra in india online</a> where can i get genuine viagra
-
WrbhBries Web Site
- August 4, 2022
cialis work [url=https://canadaviagra.com/#]which presidential candidate was the first spokesman for viagra [/url] cialis super active online australia how to use cialis for best results
-
buy generic valtrex Web Site
- August 4, 2022
Overall rates of clinical and microbiological response for CBP treated with fluoroquinolones are at the end of therapy but only after months [url=https://buycialikonline.com]cialis online generic[/url] Buy 10 Pack Of Clomid Pills
-
Entenda Web Site
- August 3, 2022
cialis online doctor <a href="https://tadalaflabc.com/ ">cialis free trial coupon</a> cialis black
-
ArfvjAmows Web Site
- August 3, 2022
when does cialis go generic <a href="https://cialpriceus.com/ ">cialis dapoxetine</a> can i buy cialis over the counter
-
Nexzgaima Web Site
- August 2, 2022
doxycycline monohydrate acne [url=https://doxycyclineus.com/#]doxycycline prescription cost uk [/url] dosage of doxycycline for dogs what is doxycycline used for?
-
valtrex 500mg us Web Site
- August 1, 2022
tadalafil side effect <a href="https://cialpriceus.com/ ">canadianmed cialis</a> cialis before and after photos
-
Nexzgaima Web Site
- July 31, 2022
where to purchase viagra in canada <a href="https://tabviagrleo.com/ ">viagra pills prescription</a> how to buy viagra in uk
-
Jikagaima Web Site
- July 31, 2022
cialis 20 mg from canada <a href="https://tadalaflabc.com/ ">cialis 5mg tadalafil</a> viagra vs cialis price
-
ArfvjAmows Web Site
- July 31, 2022
JunbNulajagma Web Site- August 6, 2022